Second Opinion in 2023!
Hello and welcome back to Second Opinion, where we’re embracing the trend of new year, new us.
We covered some incredibly exciting topics last year, from the cutting edge, with innovative pricing and decentralised clinical trials, to the fundamentals, with transformation principles and partnerships.
The trends that dominated last year around the cost of care, availability of data, and the influence of patients are only strengthening, and we are seeing organisations continue to evolve to meet the changing needs of healthcare and patients.
Against this backdrop, we at Second Opinion are sticking to our mission statement of staying relevant. Relevant to the industry, relevant to the challenges you are facing, and relevant to our expertise. In this vein, we’re kicking off 2023 with a bang, by spotlighting our experts to inform you on exactly what you should be preparing for within your organisation this year.
Through our work within the Life Sciences industry, we have spotted a range of opportunities for pharma to step up and improve their relevancy to the healthcare industry. The most competitive of organisations are already beginning to invest in many of these but in two areas most of all: Patients as Individuals, and Data Availability.
Sitting at opposite ends of the human-digital spectrum, both areas will be incredibly influential on the success of pharma companies, touching every part of the value chain from R&D to Sales.
On the one hand, we have the increase in patient choice and the need for the industry to provide them greater value. This vital movement is inspiring crucial value drivers such as patient support programmes, which help patients manage the emotional and social consequences of diseases like cancer or diabetes as well as morally imperative strategies around health equity, which is about helping patients from all backgrounds access equal quality of healthcare.
Meanwhile on the other hand we have the explosion of data which is allowing pharma companies to learn more about their customers and their patients. This in turn is reducing unnecessary costs through calculation and automation and further improving the value delivered to healthcare systems, an all-around win.
In the centre of this spectrum, there is a complex challenge to manage competing priorities as emotions meet facts. An increasing understanding that patients’ overall quality of life is as important as clinical outcomes must align with the efficiency improvements offered by automation. In this issue, you’ll hear from our experts how they actually complement each other, how the key to success in patient support is data, and how the smartest approach to data is a human-centred one.
So, without further ado, let’s dive in, and hear from the experts about what should be top of your 2023 wish list. Remember, if you want to listen to this instead you can find us on Spotify, Apple and Soundcloud.